Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Long-Term Debt

$803.00M

Quarterly · Period ending: · USD

BIO logo

BIO Long-Term Debt

Latest reported$803.00M
BIO Quarterly Long-Term Debt ($16.30M → $803.00M)
High-resolution chart · PNG

BIO long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
803,000,000
941,500,000
1,493,100,000
1,357,200,000
1,365,900,000
1,327,000,000
1,331,800,000
1,344,019,000
1,350,675,000
1,359,214,000
1,364,578,000
1,365,879,000
1,345,233,000
1,345,045,000
1,351,297,000
1,344,511,000
1,355,429,000
1,366,434,000
186,452,000
198,063,000
185,493,000
190,127,000
187,428,000
184,344,000
185,303,000
187,652,000
189,618,000
630,400,000
625,391,000
630,158,000
438,937,000
438,803,000
438,776,000
434,678,000
434,581,000
434,475,000
434,386,000
434,289,000
434,186,000
434,137,000
434,057,000
433,980,000
433,883,000
435,728,000
435,660,000
435,661,000
435,710,000
435,739,000
435,607,000
435,611,000
435,615,000
435,541,000
732,800,000
732,586,000
732,414,000
732,233,000
732,054,000
731,899,000
731,698,000
731,597,000
731,331,000
731,214,000
731,100,000
733,574,000
734,339,000
738,662,000
737,919,000
738,687,000
738,454,000
444,209,000
445,979,000
446,378,000
440,687,000
442,446,000
441,805,000
426,141,000
426,165,000
425,504,000
425,625,000
425,750,000
425,873,000
425,971,000
425,687,000
425,812,000
425,864,000
425,807,000
425,979,000
226,009,000
226,098,000
226,171,000
225,835,000
225,196,000
98,940,000
98,862,000
105,768,000
139,124,000
149,417,000
174,343,000
188,423,000
191,282,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.